The Fontan Procedure for Pediatric Tricuspid Atresia Workup

  • Author: Prema Ramaswamy, MD; Chief Editor: John Kupferschmid, MD   more...
 
Updated: Aug 4, 2011
 

Laboratory Studies

CBC count

Determine if the patient has concomitant iron deficiency anemia because this, in the presence of cyanosis and polycythemia, can increase the risk of a cerebrovascular accident in an infant.

Thrombocytopenia is not uncommon in an older child with cyanosis.

Test of prothrombin time and activated partial thromboplastin time

The results may be abnormal because of polycythemia.

Serum electrolytes and liver function tests

Results may be abnormal because of medical therapy administered to treat congestive heart failure.

ABG analysis

This is a critical test in a cyanotic newborn to confirm hypoxia.

Moreover, when this test is repeated after 100% oxygen is administered over 10 minutes, it helps in differentiating cardiac causes of cyanosis from the common pulmonary ones. In the former situation, the partial pressure of oxygen (PO2) does not exceed 150 torr because of the obligate right-to-left shunt. This has been termed the hyperoxia test.

Next

Imaging Studies

Chest radiography

Chest radiography is typically not helpful in diagnosing tricuspid atresia. In most patients, pulmonary vascular markings are diminished because of decreased pulmonary blood flow.

A right aortic arch is less common in tricuspid atresia than in tetralogy of Fallot, and it is seen in only 3-8% of patients.[11]

Electrocardiography

This is a useful test and helps narrow the differential diagnosis in a cyanotic newborn. The other 2 cyanotic heart diseases that are more common than tricuspid atresia (ie, tetralogy of Fallot and transposition of the great arteries), involve right ventricular hypertrophy. By contrast, tricuspid atresia involves left ventricular hypertrophy.

The typical ECG in tricuspid atresia demonstrates left ventricular hypertrophy and a superior left axis. Enlarged P waves suggestive of right atrial enlargement are also common.

Echocardiography

This is the primary modality for the diagnosis of tricuspid atresia. An echo-bright shelf is in the position the tricuspid valve normally occupies. Two-dimensional echocardiography can define the size and location of the chambers, great vessels, and the atrial and ventricular septal anatomy. Associated abnormalities, such as a left superior vena cava (SVC), juxtaposed atrial appendages, subaortic stenosis, and coarctation of the aorta, can also be well documented.

Blood-flow characteristics can be quantitated by using pulse and continuous-wave and color-flow Doppler methods. The pressure gradients across stenotic orifices, valves, and septal defects can be determined by using these techniques.

Fetal diagnosis is feasible and alters the outcome because of elective termination of a pregnancy.[14]

MRI

Although MRI is not used as ubiquitously as echocardiography in diagnosing tricuspid atresia, the advantages of MRI are improved delineation of extracardiac structures, such as the pulmonary artery anatomy, especially in older children.

Cardiac MRI might replace the role of cardiac catheterization before the stages of a Fontan surgery.[15]

Previous
Next

Diagnostic Procedures

In neonates, cardiac catheterization is almost never required any longer as echocardiography offers excellent details of the intracardiac anatomy. In rare cases, in the presence of a restrictive atrial septal defect it may be used to perform a balloon septostomy.

The current role of cardiac catheterization is primarily to assess the anatomy and the resistance of the pulmonary vascular bed before a bidirectional Glenn (or hemi-Fontan) operation, which is based on the similar principle of directing blood in the SVC to the pulmonary arteries. Catheterization is also performed before the modified Fontan procedure is completed. With improvements in cardiac MRI, even this role has been challenged as being unnecessary in most patients.[15]

In older children and adolescents, arteriography is used to define details important to surgical management, including the following:

  • Number and relationship of the vena cavae
  • Size of the pulmonary arteries
  • Pulmonary artery vascular resistance
Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

Prema Ramaswamy, MD  Associate Professor of Clinical Pediatrics, State University of New York Downstate; Adjunct Assistant Clinical Professor of Pediatrics, St George's University School of Medicine; Co-Director of Pediatric Cardiology, Maimonides Medical Center, Lutheran Medical Center, and Coney Island Hospital

Prema Ramaswamy, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Cardiology

Disclosure: Nothing to disclose.

Coauthor(s)

Mary C Mancini, MD, PhD  Professor and Chief of Cardiothoracic Surgery, Department of Surgery, Louisiana State University School of Medicine in Shreveport

Mary C Mancini, MD, PhD is a member of the following medical societies: American Association for Thoracic Surgery, American College of Surgeons, American Surgical Association, Phi Beta Kappa, Society of Thoracic Surgeons, and Southern Surgical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Jonah Odim, MD, PhD, MBA  Senior Medical Officer, Transplantation Immunology Branch, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Jonah Odim, MD, PhD, MBA is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Physician Executives, American College of Surgeons, American Heart Association, American Society for Artificial Internal Organs, American Society of Transplant Surgeons, Association for Academic Surgery, Association for Surgical Education, Canadian Cardiovascular Society, International Society for Heart and Lung Transplantation, National Medical Association, New York Academy of Sciences, Royal College of Physicians and Surgeons of Canada, Society of Critical Care Medicine, and Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Samuel Weinstein, MD  Associate Professor, Albert Einstein College of Medicine; Director, Department of Pediatric Cardiothoracic Surgery, The Children's Hospital at Montefiore

Samuel Weinstein, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, American Medical Association, Ohio State Medical Association, and Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

Daniel Rauch, MD, FAAP  Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine

Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine

Disclosure: Baxter Honoraria Consulting

Chief Editor

John Kupferschmid, MD  Director of Congenital Heart Surgery, Department of Surgery, Methodist Children's Hospital at San Antonio

John Kupferschmid, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, Society of Thoracic Surgeons, and Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

References

  1. Keith JD, Rowe RD, Vlad P. Tricuspid Atresia. New York, NY: Macmillan; 1958.

  2. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. May 1971;26(3):240-8. [Medline].

  3. Glenn WW. Circulatory bypass of the right side of the heart. IV. Shunt between superiorvena cava and distal right pulmonary artery; report of clinical application. N Engl J Med. Jul 17 1958;259(3):117-20. [Medline].

  4. Kreutzer G, Galindez E, Bono H, et al. An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg. Oct 1973;66(4):613-21. [Medline].

  5. Nadas AS, Fyler DC. Tricuspid Atresia. In: Pediatric Cardiology. 3rd ed. Philadelphia, PA: WB Saunders; 1972.

  6. Svensson EC, Huggins GS, Lin H, et al. A syndrome of tricuspid atresia in mice with a targeted mutation of the geneencoding Fog-2. Nat Genet. Jul 2000;25(3):353-6. [Medline].

  7. Mahle WT, Wernovsky G, Bridges ND, et al. Impact of early ventricular unloading on exercise performance in preadolescentswith single ventricle Fontan physiology. J Am Coll Cardiol. Nov 1 1999;34(5):1637-43. [Medline].

  8. Choussat A, Fontan F, Besse P. Selection Criteria for the Fontan procedure. In: Anderson RH, Shinebourne EA, eds. Paediatric Cardiology. Edinburgh: Churchill Livingstone;. 1977: 559-66.

  9. Kuhne M. Ueber zwei Faelle kongenitaler Atresie des Ostium venosum dextrum. Jahresb Kinderh. 1906;63:225.

  10. Tandon R, Edwards JE. Tricuspid atresia. A re-evaluation and classification. J Thorac Cardiovasc Surg. Apr 1974;67(4):530-42. [Medline].

  11. Dick M, Rosenthal A, Bove E. The clinical profile of tricuspid atresia. In: Tricuspid Atresia, Rao PS, ed. Mt Kisco, New York;. 1992: 117.

  12. Dick M, Fyler DC, Nadas AS. Tricuspid atresia: clinical course in 101 patients. Am J Cardiol. Sep 1975;36(3):327-37. [Medline].

  13. Weber HS, Gleason MM, Myers JL, et al. The Fontan operation in infants less than 2 years of age. J Am Coll Cardiol. Mar 15 1992;19(4):828-33. [Medline].

  14. Smythe JF, Copel JA, Kleinman CS. Outcome of prenatally detected cardiac malformations. Am J Cardiol. Jun 1 1992;69(17):1471-4. [Medline].

  15. Fogel MA. Is routine cardiac catheterization necessary in the management of patientswith single ventricles across staged Fontan reconstruction? No!. Pediatr Cardiol. Mar-Apr 2005;26(2):154-8. [Medline].

  16. Hirono K, Yoshimura N, Taguchi M, Watanabe K, Nakamura T, Ichida F, et al. Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery. J Thorac Cardiovasc Surg. Apr 28 2010;[Medline].

  17. Salim MA, DiSessa TG, Arheart KL, Alpert BS. Contribution of superior vena caval flow to total cardiac output in children.A Doppler echocardiographic study. Circulation. Oct 1 1995;92(7):1860-5. [Medline].

  18. Puga FJ, Chiavarelli M, Hagler DJ. Modifications of the Fontan operation applicable to patients with left atrioventricularvalve atresia or single atrioventricular valve. Circulation. Sep 1987;76(3 Pt 2):III53-60. [Medline].

  19. Jonas RA, Castaneda AR. Modified Fontan procedure: atrial baffle and systemic venous to pulmonary arteryanastomotic techniques. J Card Surg. Jun 1988;3(2):91-6. [Medline].

  20. de Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg. Nov 1988;96(5):682-95. [Medline].

  21. Marcelletti C, Corno A, Giannico S, Marino B. Inferior vena cava-pulmonary artery extracardiac conduit. A new form of rightheart bypass. J Thorac Cardiovasc Surg. Aug 1990;100(2):228-32. [Medline].

  22. Laschinger JC, Ringel RE, Brenner JI, McLaughlin JS. Extracardiac total cavopulmonary connection. Ann Thorac Surg. Aug 1992;54(2):371-3. [Medline].

  23. Bridges ND, Mayer JE, Lock JE, et al. Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation. Dec 1992;86(6):1762-9. [Medline].

  24. Lemler MS, Scott WA, Leonard SR, et al. Fenestration improves clinical outcome of the fontan procedure: a prospective,randomized study. Circulation. Jan 15 2002;105(2):207-12. [Medline].

  25. Monagle P, Cochrane A, Roberts R, Manlhiot et al. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic Acid as primary thromboprophylaxis for 2 years after the fontan procedure in children. J Am Coll Cardiol. Aug 2 2011;58(6):645-51. [Medline].

  26. Mertens L, Hagler DJ, Sauer U, et al. Protein-losing enteropathy after the Fontan operation: an international multicenterstudy. PLE study group. J Thorac Cardiovasc Surg. May 1998;115(5):1063-73. [Medline].

  27. Minamisawa S, Nakazawa M, Momma K, et al. Effect of aerobic training on exercise performance in patients after the Fontanoperation. Am J Cardiol. Sep 15 2001;88(6):695-8. [Medline].

  28. Coon PD, Rychik J, Novello RT, et al. Thrombus formation after the Fontan operation. Ann Thorac Surg. Jun 2001;71(6):1990-4. [Medline].

  29. Ravn HB, Hjortdal VE, Stenbog EV, et al. Increased platelet reactivity and significant changes in coagulation markersafter cavopulmonary connection. Heart. Jan 2001;85(1):61-5. [Medline].

  30. Cohen MI, Bush DM, Ferry RJ, et al. Somatic growth failure after the Fontan operation. Cardiol Young. Sep 2000;10(5):447-57. [Medline].

  31. Ono M, Boethig D, Goerler H, Lange M, Westhoff-Bleck M, Breymann T. Somatic development long after the Fontan operation: factors influencing catch-up growth. J Thorac Cardiovasc Surg. Nov 2007;134(5):1199-206. [Medline].

  32. Mahle WT, Clancy RR, Moss EM, et al. Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescentchildren with hypoplastic left heart syndrome. Pediatrics. May 2000;105(5):1082-9. [Medline].

  33. Wernovsky G, Stiles KM, Gauvreau K, et al. Cognitive development after the Fontan operation. Circulation. Aug 22 2000;102(8):883-9. [Medline].

  34. Goldberg CS, Schwartz EM, Brunberg JA, et al. Neurodevelopmental outcome of patients after the fontan operation: A comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J Pediatr. Nov 2000;137(5):646-52. [Medline].

  35. Ovroutski S, Dahnert I, Alexi-Meskishvili V, et al. Preliminary analysis of arrhythmias after the Fontan operation with extracardiacconduit compared with intra-atrial lateral tunnel. Thorac Cardiovasc Surg. Dec 2001;49(6):334-7. [Medline].

  36. McElhinney DB, Marx GR, Marshall AC, Mayer JE, Del Nido PJ. Cavopulmonary pathway modification in patients with heterotaxy and newly diagnosed or persistent pulmonary arteriovenous malformations after a modified Fontan operation. J Thorac Cardiovasc Surg. Jun 2011;141(6):1362-1370.e1. [Medline].

  37. Gaynor JW, Bridges ND, Cohen MI, et al. Predictors of outcome after the Fontan operation: is hypoplastic left heartsyndrome still a risk factor?. J Thorac Cardiovasc Surg. Feb 2002;123(2):237-45. [Medline].

  38. Earing MG, Cetta F, Driscoll DJ, et al. Long-term results of the Fontan operation for double-inlet left ventricle. Am J Cardiol. Jul 15 2005;96(2):291-8. [Medline].

  39. Wallace MC, Jaggers J, Li JS, et al. Center variation in patient age and weight at fontan operation and impact on postoperative outcomes. Ann Thorac Surg. May 2011;91(5):1445-52. [Medline].

  40. Yeh T, Williams WG, McCrindle BW, et al. Equivalent survival following cavopulmonary shunt: with or without the Fontanprocedure. Eur J Cardiothorac Surg. Aug 1999;16(2):111-6. [Medline].

  41. Alexiou C, Delany DJ, Keeton BR, Monro JL. Double-barreled conduit for right atrioventricular connection in tricuspid atresia: a new technique. J Thorac Cardiovasc Surg. Oct 2000;120(4):820-2. [Medline].

  42. Anderson RH, Wilkinson JL, Gerlis LM, et al. Atresia of the right atrioventricular orifice. Br Heart J. Apr 1977;39(4):414-28. [Medline].

  43. Annecchino FP, Fontan F, Chauve A, Quaegebeur J. Palliative reconstruction of the right ventricular outflow tract in tricuspid atresia: a report of 5 patients. Ann Thorac Surg. Apr 1980;29(4):317-21. [Medline].

  44. Behrendt DM, Rosenthal A. Cardiovascular status after repair by Fontan procedure. Ann Thorac Surg. Apr 1980;29(4):322-30. [Medline].

  45. Chopra PS, Rao PS. Corrective surgery for tricuspid atresia: which modification of Fontan-Kreutzer procedure should be used? A review. Am Heart J. Mar 1992;123(3):758-67. [Medline].

  46. Cohen MI, Bridges ND, Gaynor JW, et al. Modifications to the cavopulmonary anastomosis do not eliminate early sinusnode dysfunction. J Thorac Cardiovasc Surg. Nov 2000;120(5):891-900. [Medline].

  47. Dore A, Somerville J. Right atrioventricular extracardiac conduit as a fontan modification: late results. Ann Thorac Surg. Jan 2000;69(1):181-5. [Medline].

  48. Durongpisitkul K, Porter CJ, Cetta F, et al. Predictors of early- and late-onset supraventricular tachyarrhythmias after Fontan operation. Circulation. Sep 15 1998;98(11):1099-107. [Medline].

  49. Ensley AE, Lynch P, Chatzimavroudis GP, et al. Toward designing the optimal total cavopulmonary connection: an in vitro study. Ann Thorac Surg. Oct 1999;68(4):1384-90. [Medline].

  50. Facchini M, Guldenschuh I, Turina J, et al. Resolution of protein-losing enteropathy with standard high molecular heparin and urokinase after Fontan repair in a patient with tricuspid atresia. J Cardiovasc Surg (Torino). Aug 2000;41(4):567-70. [Medline].

  51. Franklin RC, Spiegelhalter DJ, Sullivan ID, et al. Tricuspid atresia presenting in infancy. Survival and suitability for the Fontan operation. Circulation. Feb 1993;87(2):427-39. [Medline].

  52. Freedom RM, Hamilton R, Yoo SJ, et al. The Fontan procedure: analysis of cohorts and late complications. Cardiol Young. Oct 2000;10(4):307-31. [Medline].

  53. Gale AW, Danielson GK, McGoon DC. Fontan procedure for tricuspid atresia. Circulation. Jul 1980;62(1):91-6. [Medline].

  54. Haas GS, Hess H, Black M, et al. Extracardiac conduit fontan procedure: early and intermediate results. Eur J Cardiothorac Surg. Jun 2000;17(6):648-54. [Medline].

  55. Hager A, Zrenner B, Brodherr-Heberlein S, et al. Congenital and surgically acquired Wolff-Parkinson-White syndrome in patientswith tricuspid atresia. J Thorac Cardiovasc Surg. Jul 2005;130(1):48-53. [Medline].

  56. Hess J. Long-term problems after cavopulmonary anastomosis: diagnosis and management. Thorac Cardiovasc Surg. Apr 2001;49(2):98-100. [Medline].

  57. Jaquiss RD, Ghanayem NS, Hoffman GM, et al. Early cavopulmonary anastomosis in very young infants after the Norwood procedure:impact on oxygenation, resource utilization, and mortality. J Thorac Cardiovasc Surg. Apr 2004;127(4):982-9. [Medline].

  58. Karamlou T, Ashburn DA, Caldarone CA, et al. Matching procedure to morphology improves outcomes in neonates with tricuspidatresia. J Thorac Cardiovasc Surg. Dec 2005;130(6):1503-10. [Medline].

  59. Kirklin JK, Blackstone EH, Kirklin JW, et al. The Fontan operation. Ventricular hypertrophy, age, and date of operation as risk factors. J Thorac Cardiovasc Surg. Dec 1986;92(6):1049-64. [Medline].

  60. Lee CN, Schaff HV, Danielson GK, et al. Comparison of atriopulmonary versus atrioventricular connections for modified Fontan/Kreutzer repair of tricuspid valve atresia. J Thorac Cardiovasc Surg. Dec 1986;92(6):1038-43. [Medline].

  61. Mair DD, Puga FJ, Danielson GK. The Fontan procedure for tricuspid atresia: early and late results of a 25-yearexperience with 216 patients. J Am Coll Cardiol. Mar 1 2001;37(3):933-9. [Medline].

  62. Park SC, Neches WH, Mullins CE, et al. Blade atrial septostomy: collaborative study. Circulation. Aug 1982;66(2):258-66. [Medline].

  63. Sanders SP, Wright GB, Keane JF, et al. Clinical and hemodynamic results of the Fontan operation for tricuspid atresia. Am J Cardiol. May 1982;49(7):1733-40. [Medline].

  64. Sano S, Ishino K, Kawada M, et al. Staged biventricular repair of pulmonary atresia or stenosis with intact ventricular septum. Ann Thorac Surg. Nov 2000;70(5):1501-6. [Medline].

  65. Stefanelli G, Kirklin JW, Naftel DC, et al. Early and intermediate-term (10-year) results of surgery for univentricular atrioventricular connection ("single ventricle"). Am J Cardiol. Oct 1 1984;54(7):811-21. [Medline].

  66. Takeda M, Shimada M, Sekiguchi A, Ishizawa A. Long-term results of the fenestrated Fontan operation. Progress of patients with patent fenestrations. Jpn J Thorac Cardiovasc Surg. Sep 1999;47(9):432-9. [Medline].

  67. van den Bosch AE, Roos-Hesselink JW, Van Domburg R, et al. Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol. May 1 2004;93(9):1141-5. [Medline].

  68. van Doorn CA, de Leval MR. The Fontan operation in clinical practice: indications and controversies. Nat Clin Pract Cardiovasc Med. Mar 2005;2(3):116-7. [Medline].

  69. van Son JA, Mohr FW, Hambsch J, et al. Conversion of atriopulmonary or lateral atrial tunnel cavopulmonary anastomosis to extracardiac conduit Fontan modification. Eur J Cardiothorac Surg. Feb 1999;15(2):150-7; discussion 157-8. [Medline].

  70. Weinberg PM. Anatomy of tricuspid atresia and its relevance to current forms of surgical therapy. Ann Thorac Surg. Apr 1980;29(4):306-11. [Medline].

  71. Wong ML, Sim EK, Goh JJ, et al. Bidirectional cavopulmonary anastomosis. Ann Acad Med Singapore. Mar 1999;28(2):237-40. [Medline].

 
Previous
Next
 
Polytetrafluoroethylene (PTFE, Gore-Tex; W. L. Gore & Associates, Newark, DE) patch used to fashion the lateral tunnel in the Fontan operation.
Bidirectional Glenn procedure. SVC = superior vena cava.
Completion of the bidirectional Glenn operation. SVC = superior vena cava.
Hemi-Fontan procedure.
Lateral-tunnel Fontan procedure.
Extracardiac Fontan operation.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.